Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, January 24, 2023
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
Matthew Harrison Maintained (BGNE) at Buy with Increased Target to $325 on, Jan 24th, 2023
Matthew Harrison of Morgan Stanley, Maintained "BeiGene, Ltd." (BGNE) at Buy with Increased Target from $295 to $325 on, Jan 24th, 2023.
Matthew has made no other calls on BGNE in the last 4 months.
There are 2 other peers that have a rating on BGNE. Out of the 2 peers that are also analyzing BGNE, 0 agree with Matthew's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Matthew
- Andrew Berens of "SVB Leerink" Maintained at Buy with Increased Target to $300 on, Friday, January 20th, 2023
- Michael Schmidt of "Guggenheim" Maintained at Strong Buy with Increased Target to $350 on, Friday, January 20th, 2023
